Antiflegmin ointment ointment

Страна: Вірменія

мова: англійська

Джерело: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активний інгредієнт:

camphor, phenol

Доступна з:

Vetprom AD

Код атс:

QD08AE99

ІПН (Міжнародна Ім'я):

camphor, phenol

Дозування:

2,5g/50g+ 2,5g/50g

Фармацевтична форма:

ointment

Одиниць в упаковці:

aluminium tube 50g

Тип рецепту:

Prescription

Статус Авторизація:

Registered

Дата Авторизація:

2020-06-02

інформаційний буклет

LEAFLET FOR:
ANTIFLEGMIN OINTMENT
For cattle, horses, donkeys, swine, sheep, goat, and dogs
1.
NAME AND ADDRESS OF THE AUTHORIZATION HOLDER AND OF THE PRODUCER (IF
THEY DIFFERENT)
VETPROM AD, 2400, Radomir, Bulgaria, 26, Otets Paisij Str.
Tel.: [phone]
E-mail: [e-mail]
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
ANTIFLEGMIN OINTMENT
3.
ACTIVE SUBSTANCE AND EXCIPIENTS
50 g of the ointment contain:
ACTIVE SUBSTANCE:
Phenol 2.5 g
Camphor 2.5 g
EXCIPIENTS:
Cod-liver Oil, Wool Fat and White Soft Paraffin.
4.
THERAPEUTIC INDICATIONS
Used in suppurative inflammatory processes (abscess, phlegmon,
furuncle, carbuncle; injuries; wounds (contaminated,
infected and suppurating); inflammatory postpartum swellings,
tendinitis, rupture of tendons and other diseases of the
musculoskeletal system (myositis, bursitis, complications after
fractures and castration); edema of the mammary gland,
acute and chronic mastitis.
5.
CONTRAINDICATIONS
This drug product is contraindicated in animals with a history of
sensitivity to any of its components.
Not to be used in animals from the Cats family.
6.
ADVERSE REACTIONS
Skin irritations are possible.
The frequency of the adverse reactions is defined using the following
classification:
- very common (more than 1 of 10 animals suffer from the ADR during
one treatment course);
- frequent (more than 1 but less than 10 animals out of 100 animals);
- infrequent (more than 1 but less than 10 animals out of 1 000
animals)
- rare (more than 1 but less than 10 animals out of 10 000 animals);
- very rare (less than 1 animal out of 10 000 animals, including
isolated reports).
If a serious impact or other effect, due to the use of this VMP not
listed in this leaflet is observed, please inform your
veterinarian immediately.
7.
ANIMAL SPECIES, FOR WHICH THIS VMP IS DESIGNED
Cattle, horses, donkeys, swine, sheep, goat, and dogs.
8.
RECOMMENDED DOSES FOR EACH OF THE ANIMAL SPECIES, ADMINISTRATION ROUTE
For external use. To be rubbed in 2 times daily in the injured site
until complete healin

Характеристики продукта

SUMMARY PRODUCT CHARACTERISTIC ANTIFLEGMIN
1. NAME OF THE VMP AND CONCENTRATION / ACTIVITY.
АНТИФЛЕГМИН
®
маз
ANTIFLEGMIN
®
ointment
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Phenol 2.5 g/50 g
Camphor 2.5 g/50 g
EXCIPIENTS:
For a full list of the excipients, see p. 6.1
3. PHARMACEUTICAL FORM.
Ointment for skin application.
4. CLINICAL DATA.
4.1. ANIMALS FOR WHICH THE VMP IS INTENDED.
Cattle, horses, donkeys, pigs, sheep, goats and dogs.
4.2. THERAPEUTIC INDICATIONS FOR INDIVIDUAL ANIMAL SPECIES
At purulent inflammatory processes (abscess, phlegmon, furunculus,
carbunculus); contusions;
wounds (contaminated, infected and suppurated); inflammatory postnatal
swellings, tendinitis,
ruptures of tendons and other diseases of the locomotor system
(myositis, bursitis, post-fracture
and post-castration complications), oedema of the lactic gland, acute
and chronic mastitis.
4.3. CONTRAINDICATIONS.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
Do not use in animals of Family Felidae (cats).
4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES.
None.
4.5. SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the
veterinary medicinal product to
animals
Not applicable.
4.6. ADVERSE REACTIONS (FREQUENCY AND IMPORTANCE)
Skin irritations may occur.
The frequency of adverse reactions is determined by the following
classification:
- very common (more than 1 in 10 animals exhibiting adverse reactions
during the course of one
treatment)
- common (more than 1 but less than 10 animals per 100 animals)
- uncommon (more than 1 but less than 10 animals per 1,000 animals)
- rare (more than 1 but less than 10 animals per 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated
messages).
4.7. USE DURING PREGNANCY, LACTATION OR LAYING.
It can be used during pregnancy and lactation.
4.8. INTERACTION WITH OTHER VETERINARY MEDICINAL PRODUCTS AND OTHER
FOR